Brief: Qualigen Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Rule
12/12/2022 14:02
Dec 12 (Reuters) - Qualigen Therapeutics Inc QLGN.O :
* QUALIGEN THERAPEUTICS REGAINS COMPLIANCE WITH NASDAQ
MINIMUM BID
PRICE RULE
Source text for Eikon: ID:nGNXbRsY0k
Further company coverage: QLGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aixcrypto Holdings
See all newsBrief: Aixcrypto - Enters Common Shares Purchase Agreement With Gold King Arthur Holding - SEC Filing
Chief Executive Officer And Director
Brief: Aixcrypto Holdings - Enters Note Purchase Agreement With CABG Acquisition Corp On May 12, 2026 - SEC Filing
Brief: Aixcrypto Holdings Reports First Quarter 2026 Results
AIxCrypto Q1 net loss widens as expenses rise